ValuEngine lowered shares of Vitamin Shoppe (NYSE:VSI) from a buy rating to a hold rating in a report released on Sunday morning.
A number of other equities analysts have also recently issued reports on the company. Barclays reduced their target price on Vitamin Shoppe from $6.00 to $3.00 and set an equal weight rating on the stock in a report on Thursday, November 9th. Morgan Stanley reduced their target price on Vitamin Shoppe from $7.50 to $4.00 and set an equal weight rating on the stock in a report on Thursday, November 9th. Finally, Zacks Investment Research cut Vitamin Shoppe from a hold rating to a sell rating in a report on Tuesday, November 7th. Four research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The company currently has an average rating of Hold and an average price target of $5.00.
Shares of Vitamin Shoppe (NYSE VSI) traded down $0.10 during trading hours on Friday, hitting $4.30. The stock had a trading volume of 506,800 shares, compared to its average volume of 534,050. Vitamin Shoppe has a 52 week low of $2.95 and a 52 week high of $24.85. The firm has a market capitalization of $110.30, a price-to-earnings ratio of -0.41 and a beta of 0.68. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.32 and a current ratio of 2.07.
In other news, major shareholder Vintage Capital Management Llc bought 133,804 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were purchased at an average price of $4.28 per share, for a total transaction of $572,681.12. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 1.07% of the company’s stock.
Several large investors have recently bought and sold shares of VSI. Schwab Charles Investment Management Inc. increased its holdings in shares of Vitamin Shoppe by 34.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 262,123 shares of the specialty retailer’s stock worth $3,054,000 after acquiring an additional 67,362 shares during the last quarter. GMT Capital Corp acquired a new position in shares of Vitamin Shoppe during the 3rd quarter worth approximately $3,423,000. Goldman Sachs Group Inc. increased its holdings in shares of Vitamin Shoppe by 88.5% during the 2nd quarter. Goldman Sachs Group Inc. now owns 124,077 shares of the specialty retailer’s stock worth $1,445,000 after acquiring an additional 58,243 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in shares of Vitamin Shoppe by 16.7% during the 2nd quarter. Russell Investments Group Ltd. now owns 26,788 shares of the specialty retailer’s stock worth $312,000 after acquiring an additional 3,839 shares during the last quarter. Finally, Legal & General Group Plc increased its holdings in shares of Vitamin Shoppe by 9.3% during the 2nd quarter. Legal & General Group Plc now owns 44,555 shares of the specialty retailer’s stock worth $518,000 after acquiring an additional 3,789 shares during the last quarter. 90.35% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Vitamin Shoppe (VSI) Cut to “Hold” at ValuEngine” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3125870/vitamin-shoppe-vsi-cut-to-hold-at-valuengine.html.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.